Atlas Trials

A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Intelence

Clinical trial NCT01741844 · COMPLETED

Trial details

NCT number
NCT01741844
Sponsor
Janssen Korea, Ltd., Korea
Status
COMPLETED
Study type
OBSERVATIONAL
Acquired Immune Deficiency Syndrome
Start date
2012-09-01
Primary completion
2014-07-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.